Topical application of St John's wort (Hypericum perforatum)

Planta Medica

Volumn 80, Issue 2-3, 2014, Pages 109-120

  Wölfle, Ute ^a   Seelinger, Günter ^b   Schempp, Christoph M ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Medical Services Dr Seelinger   (Germany)

Author keywords

dermatology; Hypericaceae; Hypericum perforatum; St. John's wort; topical application

Indexed keywords

ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIOXIDANTS; CELL DIFFERENTIATION; HUMANS; HYPERICUM; KERATINOCYTES; MICROBIAL SENSITIVITY TESTS; PHYTOCHEMICALS; PLANT EXTRACTS; SKIN; SKIN DISEASES; WOUND HEALING;

EID: 84894261078     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0033-1351019     Document Type: Review

References (97)

1. Pliny the Elder (23-79 A.D.) The natural history. Book XXVI, Chapter LXXX. Cited after: Bostock J, Riley HT, editors. London: Taylor and Francis; 1855. The perseus digital library. Available at: http://www.perseus.tufts.edu/ hopper/text?doc=Perseus%253atext%253a1999.02.0137 Accessed April 5, 2013
2. Blaschek W., Ebel S., Hackenthal E., Holzgrabe U., Keller K., Reichling J., Schulz V. Hagers Handbuch der pharmazeutischen Praxis. Berlin, Heidelberg Springer Verlag: 2008
3. WHO WHO-Monographs on selected medical plants. Geneva World Health Organization: 2002
4. EMEA (European Medicines Agency) HMPC Community herbal monograph on Hypericum perforatum L., herba (Traditional use). EMEA/HMPC/745582/2009. Wien Med Wochenschr: 2010; 160 557 563
5. Isacchi B., Bergonzi M. C., Carnevali F., van der Esch S. A., Vincieri F. F., Bilia A. R. Analysis and stability of the constituents of St. John's wort oils prepared with different methods. J Pharm Biomed Anal: 2007; 45 756 761 (Pubitemid 350103652)
6. German Pharmacopoeia, EB6 (Deutsches Arzneibuch. Suppl., 6th edition). Bonn Phytopharmaceutical Corporation: 1941; 409
7. Schmidt A. H. Use of an on-line, precolumn photochemical reactor in high-performance liquid chromatography of naphthodianthrones in Hypericum perforatum preparations. J Chromatogr A: 2003; 987 181 187 (Pubitemid 36140093)
8. Maisenbacher P., Kovar K. A. Analysis and stability of Hyperici oleum. Planta Med: 1992; 58 351 354
9. Verotta L., Appendino G., Jakupovic J., Bombardelli E. Hyperforin analogues from St. John's wort (Hypericum perforatum). J Nat Prod: 2000; 63 412 415 (Pubitemid 30173710)
10. Arsić I., Zugić A., Tadić V., Tasić-Kostov M., Mišić D., Primorac M., Runjaić-Antić D. Estimation of dermatological application of creams with St. John's Wort oil extracts. Molecules: 2011; 17 275 294
11. Orhan I. E., Kartal M., Gülpinar A. R., Cos P., Matheeussen A., Maes L., Tasdemir D. Assessment of antimicrobial and antiprotozoal activity of the olive oil macerate samples of Hypericum perforatum and their LC-DAD-MS analyses. Food Chem: 2013; 138 870 875
12. EMEA (European Medicines Agency) HMPC assessment report on Hypericum perforatum L., Herba. EMA/HMPC/101303/2008. London EMEA: 2009
13. Gaedcke F. Herstell- und Qualitätsaspekte pflanzlicher Extrakte. Pharmazie in unserer Zeit: 2003; 3 192 202
14. Kacerovská D., Pizinger K., Majer F., Smíd F. Photodynamic therapy of nonmelanoma skin cancer with topical Hypericum perforatum extract-a pilot study. Photochem Photobiol: 2008; 84 779 785 (Pubitemid 351589362)
15. Tardivo J. P., Wainwright M., Baptista M. S. Local clinical phototreatment of herpes infection in São Paulo. Photodiagnosis Photodyn Ther: 2012; 9 118 121
16. Schempp C. M., Lüdtke R., Winghofer B., Simon J. C. Effect of topical application of Hypericum perforatum extract (St. John's wort) on skin sensitivity to solar simulated radiation. Photodermatol Photoimmunol Photomed: 2000; 16 125 128 (Pubitemid 30367088)
17. Schempp C. M., Windeck T., Hezel S., Simon J. C. Topical treatment of atopic dermatitis with St. John's wort cream - a randomized, placebo controlled, double blind half-side comparison. Phytomedicine: 2003; 10 04 31 37 (Pubitemid 36597154)
18. Cecchini C., Cresci A., Coman M. M., Ricciutelli M., Sagratini G., Vittori S., Lucarini D., Maggi F. Antimicrobial activity of seven Hypericum entities from central Italy. Planta Med: 2007; 73 564 566 (Pubitemid 46984844)
19. Gibbons S., Ohlendorf B., Johnsen I. The genus Hypericum - a valuable resource of anti-Staphylococcal leads. Fitoterapia: 2002; 73 300 304 (Pubitemid 35286356)
20. Bystrov N. S., Dobrynin V. N., Kolosov M. N., Chernov B. K., Chervin I. I. [Structure of the chromophoric part of hyperforin]. Dokl Akad Nauk SSSR: 1975; 225 1327 1328
21. Schempp C. M., Pelz K., Wittmer A., Schöpf E., Simon J. C. Antibacterial activity of hyperforin from St John's wort, against multiresistant Staphylococcus aureus and gram-positive bacteria. Lancet: 1999; 353 2129 (Pubitemid 29278489)
22. Yow C. M., Tang H. M., Chu E. S., Huang Z. Hypericin-mediated photodynamic antimicrobial effect on clinically isolated pathogens. Photochem Photobiol: 2012; 88 626 632
23. Borchardt J. R., Wyse D. L., Sheaffer C. C., Kauppi K. L., Fulcher R. G., Ehlke N. G., Bicsboer D. D., Bey R. F. Antimicrobial activity of native and naturalized plants of Minnesota and Wisconsin. J Med Plants Res: 2008; 2 98 110
24. Avato P., Raffo F., Guglielmi G., Vitali C., Rosato A. Extracts from St John's Wort and their antimicrobial activity. Phytother Res: 2004; 18 230 232 (Pubitemid 38568750)
25. Dadgar T., Asmar M., Saifi A., Mazandarani M., Bayat H., Moradi A., Bazueri M., Ghaemi E. Antibacterial activity of certain medicinal plants against methicillin resistant and methicillin sensitive Staphylococcus aureus. Asian J Plant Sci: 2006; 5 861 866 (Pubitemid 44759621)
26. Lasik M., Nowak J., Stachowiak B., Czarnecki Z. Evaluation of the antagonistic properties of natural antibacterial substances extracted from herbs: poster presentation. Eurobiotech: 2007; 54 10 (cited after Saddiqe 2010)
27. Reichling J., Weseler A., Saller R. A current review of the antimicrobial activity of Hypericum perforatum L. Pharmacopsychiatry: 2001; 34 01 S116 S118
28. Mortensen T., Shen S., Shen F., Walsh M. K., Sims R. C., Miller C. D. Investigating the effectiveness of St John's wort herb as an antimicrobial agent against Mycobacteria. Phytother Res: 2012; 26 1327 1333
29. Peeva-Naumovska V., Panovski N., Grdanovska T., Fredro-Kumbaradzi E. Formulations of St. John's Wort oil ointment and evaluation of its antibacterial effect. Available at http://www.amapseec.org/cmapseec.1/papers/pap-p067.htm 2000. Accessed April 28, 2013
30. Saddiqe Z., Naeem I., Maimoona A. A review of the antibacterial activity of Hypericum perforatum L. J Ethnopharmacol: 2010; 131 511 521
31. Birt D. F., Widrlechner M. P., Hammer K. D., Hillwig M. L., Wei J., Kraus G. A., Murphy P. A., McCoy J., Wurtele E. S., Neighbors J. D., Wiemer D. F., Maury W. J., Price J. P. Hypericum in infection: Identification of anti-viral and anti-inflammatory constituents. Pharm Biol: 2009; 47 774 782
32. Klemow K. M., Bartlow A., Crawford J., Kocher N., Shah J., Ritsick M. Medical attributes of St. John's Wort (Hypericum perforatum). In: Benzie I. FF, Wachtel-Galor S. editors Herbal medicine: biomolecular and clinical aspects. 2nd edition. Boca Raton CRC Press: 2011; (Chapter 11)
33. Takahashi I., Nakanishi S., Kobayashi E., Nakano H., Suzuki K., Tamaoki T. Hypericin and pseudohypericin specifically inhibit protein kinase C: possible relation to their antiretroviral activity. Biochem Biophys Res Commun: 1989; 165 1207 1212 (Pubitemid 20029836)
34. Gulick R. M., McAuliffe V., Holden-Wiltse J., Crumpacker C., Liebes L., Stein D. S., Meehan P., Hussey S., Forcht J., Valentine F. T. Phase I studies of hypericin, the active compound in St. John's Wort, as an antiretroviral agent in HIV-infected adults. AIDS Clinical Trials Group Protocols 150 and 258. Ann Intern Med: 1999; 130 510 514 (Pubitemid 29135804)
35. Maury W., Price J. P., Brindley M. A., Oh C., Neighbors J. D., Wiemer D. F., Wills N., Carpenter S., Hauck C., Murphy P., Widrlechner M. P., Delate K., Kumar G., Kraus G. A., Rizshsky L., Nikolau B. Identification of light-independent inhibition of human immunodeficiency virus-1 infection through bioguided fractionation of Hypericum perforatum. Virol J: 2009; 6 101
36. López-Chicón P., Paz-Cristobal M. P., Rezusta A., Aspiroz C., Royo-Cañas M., Andres-Ciriano E., Gilaberte Y., Agut M., Nonell S. On the mechanism of Candida spp. photoinactivation by hypericin. Photochem Photobiol Sci: 2012; 11 1099 1107
37. Khosa R. L., Bhatia N. Antifungal effect of Hypericum perforatum Linn. J Sci Res Plant Med: 1982; 3 49 50
38. Hunt E. J., Lester C. E., Lester E. A., Tackett R. L. Effect of St. John's wort on free radical production. Life Sci: 2001; 69 181 190 (Pubitemid 32523074)
39. Benedi J., Arroyo R., Romero C., Martin-Aragon S., Villar A. M. Antioxidant properties and protective effects of a standardized extract of Hypericum perforatum on hydrogen peroxide-induced oxidative damage in PC12 cells. Life Sci: 2004; 75 1263 1276 (Pubitemid 38829351)
40. Jang M. H., Lee T. H., Shin M. C., Bahn G. H., Kim J. W., Shin D. H., Kim E. H., Kim C. J. Protective effect of Hypericum perforatum Linn (St. John's wort) against hydrogen peroxide-induced apoptosis on human neuroblastoma cells. Neurosci Lett: 2002; 329 177 180
41. Sagratini G., Ricciutelli M., Vittori S., Oztürk N., Oztürk Y., Maggi F. Phytochemical and antioxidant analysis of eight Hypericum taxa from Central Italy. Fitoterapia: 2008; 79 210 213
42. Rainha N., Lima E., Baptista J. Comparison of the endemic Azorean Hypericum foliosum with other Hypericum species: antioxidant activity and phenolic profile. Nat Prod Res: 2011; 25 123 135
43. Zou Y., Lu Y., Wei D. Antioxidant activity of a flavonoid-rich extract of Hypericum perforatum L. in vitro. J Agric Food Chem: 2004; 52 5032 5039
44. Meinke M. C., Schanzer S., Haag S. F., Casetti F., Müller M. L., Wölfle U., Kleemann A., Lademann J., Schempp C. M. In vivo photoprotective and anti-inflammatory effect of hyperforin is associated with high antioxidant activity in vitro and ex vivo. Eur J Pharm Biopharm: 2012; 81 346 350
45. Onoue S., Seto Y., Ochi M., Inoue R., Ito H., Hatano T., Yamada S. In vitro photochemical and phototoxicological characterization of major constituents in St. John's Wort (Hypericum perforatum) extracts. Phytochemistry: 2011; 72 1814 1820
46. Schempp C. M., Müller K., Winghofer B., Schulte-Mönting J., Simon J. C. Single-dose and steady-state administration of Hypericum perforatum extract (St John's Wort) does not influence skin sensitivity to UV radiation, visible light, and solar-simulated radiation. Arch Dermatol: 2001; 137 512 513 (Pubitemid 32319861)
47. Traynor N. J., Beattie P. E., Ibbotson S. H., Moseley H., Ferguson J., Woods J. A. Photogenotoxicity of hypericin in HaCaT keratinocytes: implications for St. John's Wort supplements and high dose UVA-1 therapy. Toxicol Lett: 2005; 158 220 224 (Pubitemid 41074818)
48. Schmitt L. A., Liu Y., Murphy P. A., Petrich J. W., Dixon P. M., Birt D. F. Reduction in hypericin-induced phototoxicity by Hypericum perforatum extracts and pure compounds. J Photochem Photobiol B: 2006; 85 118 130 (Pubitemid 44542577)
49. Boiy A., Roelandts R., van den Oord J., de Witte P. A. Photosensitizing activity of hypericin and hypericin acetate after topical application on normal mouse skin. Br J Dermatol: 2008; 158 360 369
50. Sosa S., Pace R., Bornancin A., Morazzoni P., Riva A., Tubaro A., Della Loggia R. Topical anti-inflammatory activity of extracts and compounds from Hypericum perforatum L. J Pharm Pharmacol: 2007; 59 703 709 (Pubitemid 47051114)
51. Kang B. Y., Chung S. W., Kim T. S. Inhibition of interleukin-12 production in lipopolysaccharide-activated mouse macrophages by hpyericin, an active component of Hypericum perforatum. Planta Med: 2001; 67 364 366 (Pubitemid 32588577)
52. Albert D., Zündorf I., Dingermann T., Müller W. E., Steinhilber D., Werz O. Hyperforin is a dual inhibitor of cyclooxygenase-1 and 5-lipoxygenase. Biochem Pharmacol: 2002; 64 1767 1775 (Pubitemid 35355728)
53. Hammer K. D., Hillwig M. L., Solco A. K., Dixon P. M., Delate K., Murphy P. A., Wurtele E. S., Birt D. F. Inhibition of prostaglandin E(2) production by anti-inflammatory Hypericum perforatum extracts and constituents in RAW264.7 Mouse Macrophage Cells. J Agric Food Chem: 2007; 55 7323 7331 (Pubitemid 47492285)
54. Koeberle A., Rossi A., Bauer J., Dehm F., Verotta L., Northoff H., Sautebin L., Werz O. Hyperforin, an Anti-Inflammatory Constituent from St. John's Wort, Inhibits Microsomal Prostaglandin E(2) Synthase-1 and Suppresses Prostaglandin E(2) Formation in vivo. Front Pharmacol: 2011; 2 7
55. Feisst C., Pergola C., Rakonjac M., Rossi A., Koeberle A., Dodt G., Hoffmann M., Hoernig C., Fischer L., Steinhilber D., Franke L., Schneider G., Rådmark O., Sautebin L., Werz O. Hyperforin is a novel type of 5-lipoxygenase inhibitor with high efficacy in vivo. Cell Mol Life Sci: 2009; 66 2759 2771
56. Heilmann J., Winkelmann K., Sticher O. Studies on the antioxidative activity of phloroglucinol derivatives isolated from Hypericum species. Planta Med: 2003; 69 202 206 (Pubitemid 36470122)
57. Cabrelle A., Dell'Aica I., Melchiori L., Carraro S., Brunetta E., Niero R., Scquizzato E., D'Intino G., Calzà L., Garbisa S., Agostini C. Hyperforin down-regulates effector function of activated T lymphocytes and shows efficacy against Th1-triggered CNS inflammatory-demyelinating disease. J Leukoc Biol: 2008; 83 212 219
58. Schempp C. M., Winghofer B., Lüdtke R., Simon-Haarhaus B., Schöpf E., Simon J. C. Topical application of St John's wort (Hypericum perforatum L.) and of its metabolite hyperforin inhibits the allostimulatory capacity of epidermal cells. Br J Dermatol: 2000; 142 979 984 (Pubitemid 30304612)
59. Schempp C. M., Simon-Haarhaus B., Simon J. C. Phototoxic and apoptosis-inducing capacity of pseudohypericin. Planta Med: 2002; 68 171 173 (Pubitemid 34169415)
60. Schempp C. M., Simon-Haarhaus B., Termeer C. C., Simon J. C. Hypericin photo-induced apoptosis involves the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and activation of caspase-8. FEBS Lett: 2001; 493 26 30 (Pubitemid 32241170)
61. Sharma K. V., Davids L. M. Hypericin-PDT-induced rapid necrotic death in human squamous cell carcinoma cultures after multiple treatment. Cell Biol Int: 2012; 36 1261 1266
62. Sharma K. V., Davids L. M. Depigmentation in melanomas increases the efficacy of hypericin-mediated photodynamic-induced cell death. Photodiagnosis Photodyn Ther: 2012; 9 156 163
63. Menichini G., Alfano C., Marrelli M., Toniolo C., Provenzano E., Statti G. A., Nicoletti M., Menichini F., Conforti F. Hypericum perforatum L. subsp. perforatum induces inhibition of free radicals and enhanced phototoxicity in human melanoma cells under ultraviolet light. Cell Prolif: 2013; 46 193 202
64. Huntosova V., Nadova Z., Dzurova L., Jakusova V., Sureau F., Miskovsky P. Cell death response of U87 glioma cells on hypericin photoactivation is mediated by dynamics of hypericin subcellular distribution and its aggregation in cellular organelles. Photochem Photobiol Sci: 2012; 11 1428 1436
65. Ritz R., Scheidle C., Noell S., Roser F., Schenk M., Dietz K., Strauss W. SL. In vitro comparison of hypericin and 5-aminolevulinic acid-derived protoporphyrin IX for photodynamic inactivation of medulloblastoma cells. PLoS ONE: 2012; 7 e51974
66. Šemeláková M., Mikeš J., JendŽ elovský R., Fedoročko P. The pro-apoptotic and anti-invasive effects of hypericin-mediated photodynamic therapy are enhanced by hyperforin or aristoforin in HT-29 colon adenocarcinoma cells. J Photochem Photobiol B: 2012; 117 115 125
67. Schempp C. M., Kirkin V., Simon-Haarhaus B., Kersten A., Kiss J., Termeer C. C., Gilb B., Kaufmann T., Borner C., Sleeman J. P., Simon J. C. Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. John's wort that acts by induction of apoptosis. Oncogene: 2002; 21 1242 1250 (Pubitemid 34185241)
68. Merhi F., Tang R., Piedfer M., Mathieu J., Bombarda I., Zaher M., Kolb J. P., Billard C., Bauvois B. Hyperforin inhibits Akt1 kinase activity and promotes caspase-mediated apoptosis involving Bad and Noxa activation in human myeloid tumor cells. PLoS One: 2011; 6 e25963
69. Hostanska K., Reichling J., Bommer S., Weber M., Saller R. Hyperforin a constituent of St John's wort (Hypericum perforatum L.) extract induces apoptosis by triggering activation of caspases and with hypericin synergistically exerts cytotoxicity towards human malignant cell lines. Eur J Pharm Biopharm: 2003; 56 121 132 (Pubitemid 36802055)
70. Schempp C. M., Kiss J., Kirkin V., Averbeck M., Simon-Haarhaus B., Kremer B., Termeer C. C., Sleeman J., Simon J. C. Hyperforin acts as an angiogenesis inhibitor. Planta Med: 2005; 71 999 1004
71. Dajas F. Life or death: neuroprotective and anticancer effects of quercetin. J Ethnopharmacol: 2012; 143 383 396
72. Romagnolo D. F., Selmin O. I. Flavonoids and cancer prevention: a review of the evidence. J Nutr Gerontol Geriatr: 2012; 31 206 238
73. Mukherjee P. K., Verpoorte R., Suresh B. Evaluation of in-vivo wound healing activity of Hypericum patulum (Family: Hypericaceae) leaf extract on different wound model in rats. J Ethnopharmacol: 2000; 70 315 321 (Pubitemid 30317370)
74. Süntar I. P., Akkol E. K., Yilmazer D., Baykal T., Kirmizibekmez H., Alper M., YeŚilada E. Investigations on the in vivo wound healing potential of Hypericum perforatum L. J Ethnopharmacol: 2010; 127 468 477
75. Castro F. C., Magre A., Cherpinski R., Zelante P. M., Neves L. M., Esquisatto M. A., Mendonça F. A., Santos G. M. Effects of microcurrent application alone or in combination with topical Hypericum perforatum L. and Arnica montana L. on surgically induced wound healing in Wistar rats. Homeopathy: 2012; 101 147 153
76. Öztürk N., Korkmaz S., Ozturk Y. Wound-healing activity of St. John's Wort (Hypericum perforatum L.) on chicken embryonic fibroblasts. J Ethnopharmacol: 2006; 111 33 39
77. Hostanska K., Rostock M., Melzer J., Baumgartner S., Saller R. A homeopathic remedy from arnica, marigold, St. John's wort and comfrey accelerates in vitro wound scratch closure of NIH 3 T3 fibroblasts. BMC Complement Altern Med: 2012; 12 100
78. Leuner K., Kraus M., Woelfle U., Beschmann H., Harteneck C., Boehncke W. H., Schempp C. M., Müller W. E. Reduced TRPC channel expression in psoriatic keratinocytes is associated with impaired differentiation and enhanced proliferation. PLoS One: 2011; 6 e14716
79. Müller M., Essin K., Hill K., Beschmann H., Rubant S., Schempp C. M., Gollasch M., Boehncke W. H., Harteneck C., Müller W. E., Leuner K. Specific TRPC6 channel activation, a novel approach to stimulate keratinocyte differentiation. J Biol Chem: 2008; 283 33942 33954
80. Chen W. C., Liou S. S., Tzeng T. F., Lee S. L., Liu I. M. Effect of topical application of chlorogenic acid on excision wound healing in rats. Planta Med: 2013; Apr 8. [Epub ahead of print]
81. CEBM - Oxford Centre for Evidence Based Medicine Levels of evidence. March 2009. Available at http://www.cebm.net/?o=1025 Accessed April 30, 2013
82. Saljic J. Ointment for the treatment of burns. Ger Offen: 1975; 2 406 452
83. Lomagno P., Lomagno R. C. Activity of Hypericum perforatum oil in the treatment of the bed sores in old people. Fitoterapia: 1979; 50 201 205 (Pubitemid 10118552)
84. Kundaković T., Milenković M., Zlatković S., Nikolić V., Nikolić G., Binić I. Treatment of venous ulcers with the herbal-based ointment Herbadermal®: a prospective non-randomized pilot study. Forsch Komplementmed: 2012; 19 26 30
85. Lavagna S. M., Secci D., Chimenti P., Bonsignore L., Ottaviani A., Bizzarri B. Efficacy of Hypericum and Calendula oils in the epithelial reconstruction of surgical wounds in childbirth with caesarean section. Farmaco: 2001; 56 451 453 (Pubitemid 32622116)
86. Samadi S., Khadivzadeh T., Emami A., Moosavi N. S., Tafaghodi M., Behnam H. R. The effect of Hypericum perforatum on the wound healing and scar of cesarean. J Alternat Complement Med: 2010; 16 113 117
87. Läuchli S., Hafner J., Wehrmann C., French L. E., Hunziker T. Post-surgical scalp wounds with exposed bone treated with a plant-derived wound therapeutic. J Wound Care: 2012; 21 228 230, 232-233
88. Najafizadeh P., Hashemian F., Mansouri P., Farshi S., Surmaghi M. S., Chalangari R. The evaluation of the clinical effect of topical St Johns wort (Hypericum perforatum L.) in plaque type psoriasis vulgaris: a pilot study. Australas J Dermatol: 2012; 53 131 135
89. Mannel M., Koytchev R., Dundarov S. Oral hypericum extract LI 160 is an effective treatment of recurrent herpes genitalis and herpes labialis. Phytomedicine: 2000; 7 02 17
90. Clewell A., Barnes M., Endres J. R., Ahmed M., Ghambeer D. K. Efficacy and tolerability assessment of a topical formulation containing copper sulfate and Hypericum perforatum on patients with herpes skin lesions: a comparative, randomized controlled trial. J Drugs Dermatol: 2012; 11 209 215
91. Alecu M., Ursaciuc C., Hãlãlãu F., Coman G., Merlevede W., Waelkens E., de Witte P. Photodynamic treatment of basal cell carcinoma and squamous cell carcinoma with hypericin. Anticancer Res: 1998; 18 4651 4654 (Pubitemid 29042039)
92. Dirschka T. and AK-CT002 Study Group Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo. Br J Dermatol: 2012; 166 137 146
93. Heinrich U., Tronnier H. Wirksamkeit und Verträglichkeit eines Johanniskraut-Extraktes zur Pflege der atopischen Haut. Kosmetische Med: 2003; 124 133 136
94. Arndt S., Haag S. F., Kleemann A., Lademann J., Meinke M. C. Radical protection in the visible and infrared by a hyperforin-rich cream - in vivo versus ex vivo methods. Exp Dermatol: 2013; 22 354 357
95. Haag S. F., Tscherch K., Arndt S., Kleemann A., Gersonde I., Lademann J., Rohn S., Meinke M. C. Enhancement of skin radical scavenging activity and stratum corneum lipids after the application of a hyperforin-rich cream. Eur J Pharm Biopharm: 2013; Jun 26 [pii: S0939-6411(13)00235-X]. 10.1016/j.ejpb.2013. 06.016 [Epub ahead of print]
96. CIR - Cosmetic Ingredient Review Final report on the safety assessment of Hypericum perforatum extract and Hypericum perforatum oil. Int J Toxicol: 2001; 20 02 31 39
97. Reuter J., Huyke C., Scheuvens H., Ploch M., Neumann K., Jakob T., Schempp C. M. Skin tolerance of a new bath oil containing St. John's wort extract. Skin Pharmacol Physiol: 2008; 21 306 311